S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
MarketBeat Week in Review – 1/30 - 2/3
A gold storm is coming… (Ad)
State of the Union: Biden sees economic glow, GOP sees gloom
Why a new Alzheimer's drug is having a slow US debut
A gold storm is coming… (Ad)
Sri Lanka marks independence anniversary amid economic woes
Tesla hikes price of Model Y after US alters tax credit rule
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Disney World unions vote down offer covering 45,000 workers
Route to Super Bowl dangerous for Mexico's avocado haulers
NASDAQ:MDRX

Veradigm - MDRX Stock Forecast, Price & News

$17.30
0.00 (0.00%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$17.20
$17.54
50-Day Range
$17.05
$19.59
52-Week Range
$13.59
$23.25
Volume
976,197 shs
Average Volume
1.16 million shs
Market Capitalization
$1.89 billion
P/E Ratio
40.23
Dividend Yield
N/A
Price Target
$22.92

Veradigm MarketRank™ Forecast

Analyst Rating
Hold
2.43 Rating Score
Upside/​Downside
32.5% Upside
$22.92 Price Target
Short Interest
Bearish
10.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.62
Upright™ Environmental Score
News Sentiment
0.30mentions of Veradigm in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$1.14 M Sold Last Quarter
Proj. Earnings Growth
6.15%
From $0.65 to $0.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.34 out of 5 stars

Business Services Sector

90th out of 321 stocks

Computer Integrated Systems Design Industry

8th out of 37 stocks

MDRX stock logo

About Veradigm (NASDAQ:MDRX) Stock

Veradigm, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segments. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The firm solutions include All EMRs, All Population Health Management, Patient Engagement, and Precision Medicine. The company was founded in 1986 and is headquartered in Chicago, IL.

Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

MDRX Stock News Headlines

Veradigm (NASDAQ:MDRX) Shares Gap Down to $17.91
Veradigm (NASDAQ:MDRX) Downgraded to "Neutral" at Piper Sandler
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Analysts Set Veradigm Inc. (NASDAQ:MDRX) PT at $22.67
Veradigm (NASDAQ:MDRX) Sees Strong Trading Volume
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Veradigm Building Momentum Across All Markets
Veradigm Announces Strategic Investment in Holmusk
SVB Securities Reaffirms Their Buy Rating on Allscripts (MDRX)
AllScripts Healthcare (MDRX) Q3 Earnings Top Estimates
Allscripts announces third quarter of 2022 results
Allscripts Healthcare Solutions, Inc. (MDRX)
See More Headlines
Receive MDRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Veradigm and its competitors with MarketBeat's FREE daily newsletter.

MDRX Company Calendar

Last Earnings
11/04/2021
Today
2/04/2023
Next Earnings (Confirmed)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
Health Care Technology
Current Symbol
NASDAQ:MDRX
CUSIP
01988P10
Employees
8,000
Year Founded
1986

Price Target and Rating

Average Stock Price Forecast
$22.92
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$18.50
Forecasted Upside/Downside
+32.5%
Consensus Rating
Hold
Rating Score (0-4)
2.43
Research Coverage
7 Analysts

Profitability

Net Income
$134.44 million
Pretax Margin
14.59%

Debt

Sales & Book Value

Annual Sales
$1.50 billion
Cash Flow
$2.75 per share
Book Value
$11.49 per share

Miscellaneous

Free Float
106,758,000
Market Cap
$1.89 billion
Optionable
Optionable
Beta
1.01

Social Links


Key Executives

  • Richard J. PoultonRichard J. Poulton
    Chief Executive Officer & Director
  • Thomas Langan
    President
  • Leah Jones
    Chief Financial & Accounting Officer
  • Joseph R. Rostock
    Chief Technology Officer & SVP-Product Engineering
  • Tejal Vakharia
    Senior VP-Marketing & Government Affairs













MDRX Stock - Frequently Asked Questions

Should I buy or sell Veradigm stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Veradigm in the last year. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MDRX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MDRX, but not buy additional shares or sell existing shares.
View MDRX analyst ratings
or view top-rated stocks.

What is Veradigm's stock price forecast for 2023?

7 Wall Street analysts have issued 12 month target prices for Veradigm's shares. Their MDRX share price forecasts range from $18.50 to $26.00. On average, they anticipate the company's stock price to reach $22.92 in the next twelve months. This suggests a possible upside of 32.5% from the stock's current price.
View analysts price targets for MDRX
or view top-rated stocks among Wall Street analysts.

How have MDRX shares performed in 2023?

Veradigm's stock was trading at $17.64 on January 1st, 2023. Since then, MDRX stock has decreased by 1.9% and is now trading at $17.30.
View the best growth stocks for 2023 here
.

Are investors shorting Veradigm?

Veradigm saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 10,740,000 shares, an increase of 21.6% from the December 31st total of 8,830,000 shares. Based on an average trading volume of 1,300,000 shares, the short-interest ratio is currently 8.3 days. Approximately 10.1% of the company's stock are sold short.
View Veradigm's Short Interest
.

When is Veradigm's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our MDRX earnings forecast
.

How can I listen to Veradigm's earnings call?

Veradigm will be holding an earnings conference call on Thursday, February 23rd at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Veradigm's earnings last quarter?

Veradigm Inc. (NASDAQ:MDRX) announced its quarterly earnings data on Thursday, November, 4th. The software maker reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.09. The software maker earned $369 million during the quarter, compared to analysts' expectations of $376.09 million. Veradigm had a net margin of 7.25% and a trailing twelve-month return on equity of 10.74%. The company's quarterly revenue was down 8.2% compared to the same quarter last year. During the same quarter last year, the business earned $0.15 earnings per share.

How will Veradigm's stock buyback program work?

Veradigm announced that its board has authorized a share repurchase plan on Wednesday, May 26th 2021, which allows the company to buyback $350,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase up to 14% of its stock through open market purchases. Stock buyback plans are usually an indication that the company's management believes its shares are undervalued.

What guidance has Veradigm issued on next quarter's earnings?

Veradigm issued an update on its FY 2023 earnings guidance on Wednesday, January, 11th. The company provided earnings per share guidance of $0.90-$1.00 for the period, compared to the consensus estimate of $0.95. The company issued revenue guidance of $640.00 million-$660.00 million, compared to the consensus revenue estimate of $656.84 million.

What is Paul Black's approval rating as Veradigm's CEO?

796 employees have rated Veradigm Chief Executive Officer Paul Black on Glassdoor.com. Paul Black has an approval rating of 65% among the company's employees.

What other stocks do shareholders of Veradigm own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Veradigm investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

What is Veradigm's stock symbol?

Veradigm trades on the NASDAQ under the ticker symbol "MDRX."

Who are Veradigm's major shareholders?

Veradigm's stock is owned by a number of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (4.05%), Peregrine Capital Management LLC (0.55%), Allspring Global Investments Holdings LLC (0.26%), SG Americas Securities LLC (0.22%), New York State Teachers Retirement System (0.17%) and Nisa Investment Advisors LLC (0.14%). Insiders that own company stock include Brian Farley, David B Stevens, Dennis Olis, Elaina Shekhter, Elizabeth Ann Altman, Greg Garrison, Leah Jones, Lisa Khorey, Michael Klayko, Paul Black, Richard J Poulton, Tejal Vakharia and Thomas Langan.
View institutional ownership trends
.

How do I buy shares of Veradigm?

Shares of MDRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Veradigm's stock price today?

One share of MDRX stock can currently be purchased for approximately $17.30.

How much money does Veradigm make?

Veradigm (NASDAQ:MDRX) has a market capitalization of $1.89 billion and generates $1.53 billion in revenue each year. The software maker earns $134.44 million in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does Veradigm have?

The company employs 8,000 workers across the globe.

Does Veradigm have any subsidiaries?
The following companies are subsidiares of Veradigm: HealthGrid, Practice Fusion, and ZappRx.
Read More
How can I contact Veradigm?

Veradigm's mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The official website for the company is www.allscripts.com. The software maker can be reached via phone at (800) 334-8534, via email at stephen.shulstein@allscripts.com, or via fax at 313-322-9600.

This page (NASDAQ:MDRX) was last updated on 2/5/2023 by MarketBeat.com Staff